US Stock MarketDetailed Quotes
ATXS Astria Therapeutics Inc
- 10.390
- -0.110-1.05%
Close Nov 29 13:00 ET
- 10.350
- -0.040-0.38%
Post 17:01 ET
586.35MMarket Cap-4766P/E (TTM)
10.590High10.325Low139.47KVolume10.500Open10.500Pre Close1.45MTurnover0.46%Turnover RatioLossP/E (Static)56.43MShares16.90052wk High2.38P/B318.08MFloat Cap4.67052wk Low--Dividend TTM30.61MShs Float1017.600Historical High--Div YieldTTM2.53%Amplitude2.360Historical Low10.419Avg Price1Lot Size
About Astria Therapeutics Inc Company
Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway. The company was founded by Michael R. Jirousek, Jill C. Milne and Steven E. Shoelson on June 26, 2008 and is headquartered in Boston, MA.
Company Profile
SymbolATXS
Company NameAstria Therapeutics Inc
Listing DateJun 25, 2015
Issue Price12.00
Founded2008
CEODr. Jill C. Milne, PhD
MarketNASDAQ
Employees59
Fiscal Year Ends12-31
Address22 Boston Wharf Road,10th floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-617-349-1971
Websitehttp://www.astriatx.com
Company Executives
- Name
- Position
- Salary
- Dr. Jill C. Milne, PhD
- Director, President and Chief Executive Officer
- 2.96M
- Noah Clauser
- Chief Financial Officer, Principal Accounting Officer and Treasurer
- 1.35M
- Dr. Christopher Morabito, M.D.
- Chief Medical Officer
- 1.32M
- Benjamin Harshbarger
- Chief Legal Officer
- --
- Andrea Matthews
- Chief Business Officer
- --
- Andrew Komjathy
- Chief Commercial Officer
- --
- Kenneth M. Bate
- Chairman of the Board
- 194.17K
- Dr. Sunil Agarwal, M.D.
- Director
- --
- Hugh M. Cole
- Independent Director
- 151.17K
- Gregg Anthony Lapointe, C.P.A.,M.B.A.
- Independent Director
- 163.67K
- Frederick C. Callori
- Independent Director
- 152.67K
- Michael D. Kishbauch
- Independent Director
- 157.67K
- Dr. Joanne T. Beck, PhD
- Independent Director
- 256.17K
- Dr. Jonathan Violin, M.B.A.,PhD
- Independent Director
- 158.67K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data